MACKEY CATHERINE J 4

What Happened

• Catherine J. Mackey, a director of Voyager Therapeutics, was granted a stock option award covering 30,000 shares on 2026-06-09. The reported transaction shows $0.00 paid at grant (derivative award), and no shares were sold or purchased outright in this filing.
• This grant is a compensation award (transaction code A) rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-09; Form 4 filed: 2026-06-11 (timely).
• Reported price at grant: $0.00; transaction type: Award/Grant of a derivative (option).
• Shares owned after transaction: Not specified in the filing excerpt provided.
• Footnote: The option was issued under Voyager’s 2025 Stock Incentive Plan per the director compensation policy. Vesting commencement = grant date; all shares vest on the earlier of the one-year anniversary or the next annual meeting of stockholders, subject to continued service.
• Remarks: Exhibit 24 (Power of Attorney) included in the filing.

Context

• This is a standard director compensation grant, not an exercised option or sale. No cash was exchanged at grant; the economic value will depend on future vesting and any exercise terms and the company’s stock price.
• Such grants are routine for non-employee directors and are compensation rather than a direct signal of buying or selling intent.